Total Payments
$2,723
2024 Payments
$145.72
Companies
22
Transactions
136
Medicare Patients
777
Medicare Billing
$121,671
Payment Breakdown by Category
Food & Beverage$2,723 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,723 | 136 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $335.59 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $271.86 | 16 | $0 (2024) |
| Novo Nordisk Inc | $223.00 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $220.47 | 11 | $0 (2023) |
| AbbVie, Inc. | $204.81 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $191.89 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $165.32 | 9 | $0 (2023) |
| Gilead Sciences, Inc. | $163.29 | 8 | $0 (2023) |
| Merck Sharp & Dohme LLC | $158.94 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $133.00 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.72 | 8 | AstraZeneca Pharmaceuticals LP ($39.31) |
| 2023 | $453.48 | 22 | Novo Nordisk Inc ($77.71) |
| 2022 | $809.96 | 44 | Janssen Pharmaceuticals, Inc ($106.54) |
| 2021 | $373.38 | 18 | Amgen Inc. ($93.71) |
| 2020 | $224.27 | 13 | GlaxoSmithKline, LLC. ($68.50) |
| 2019 | $150.59 | 6 | ACIST MEDICAL SYSTEMS, INC. ($55.97) |
| 2018 | $271.93 | 12 | AbbVie, Inc. ($104.81) |
| 2017 | $293.72 | 13 | AbbVie, Inc. ($100.00) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Respiratory | ||||||
| 06/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Inflammation | ||||||
| 03/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Endocrinology | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Respiratory | ||||||
| 01/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Inflammation | ||||||
| 01/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardio-renal | ||||||
| 12/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: WOMENS HEALTH | ||||||
| 08/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 07/21/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/30/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.36 | General |
| 06/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 06/16/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Inflammation | ||||||
| 04/26/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Respiratory | ||||||
| 04/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/22/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/03/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/24/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Endocrinology | ||||||
| 02/23/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Diabetes | ||||||
| 02/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 155 | 225 | $69,379 | $23,270 |
| 2022 | 4 | 185 | 295 | $97,334 | $30,148 |
| 2021 | 4 | 189 | 297 | $99,290 | $31,133 |
| 2020 | 7 | 248 | 577 | $108,009 | $37,120 |
Total Patients
777
Total Services
1,394
Medicare Billing
$121,671
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 110 | $32,391 | $9,929 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $13,362 | $5,601 | 41.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 33 | $13,952 | $3,786 | 27.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 14 | $6,374 | $2,243 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 24 | $3,300 | $1,710 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 153 | $49,572 | $14,214 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 55 | $23,980 | $7,348 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 45 | 45 | $16,070 | $5,782 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 42 | $7,712 | $2,804 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 143 | $45,170 | $12,767 | 28.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 78 | $33,590 | $10,666 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $13,600 | $5,669 | 41.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 32 | $6,930 | $2,031 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 51 | 308 | $44,660 | $17,253 | 38.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 133 | $27,496 | $7,272 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 43 | 50 | $20,750 | $5,599 | 27.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 29 | $7,330 | $3,048 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $5,027 | $2,858 | 56.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 17 | $2,146 | $825.92 | 38.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 15 | 15 | $600.00 | $263.40 | 43.9% |
About Dr. Usha Agarwal, MD
Dr. Usha Agarwal, MD is a Internal Medicine healthcare provider based in Trinity, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427043421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Usha Agarwal, MD has received a total of $2,723 in payments from pharmaceutical and medical device companies, with $145.72 received in 2024. These payments were reported across 136 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,723).
As a Medicare-enrolled provider, Agarwal has provided services to 777 Medicare beneficiaries, totaling 1,394 services with total Medicare billing of $121,671. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Trinity, FL
- Active Since 09/15/2005
- Last Updated 05/02/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427043421
Products in Payments
- TRELEGY ELLIPTA (Drug) $213.05
- Repatha (Biological) $197.83
- XARELTO (Drug) $163.70
- VERQUVO (Drug) $138.40
- ELIQUIS (Drug) $120.71
- Mavyret (Drug) $104.81
- FARXIGA (Drug) $103.86
- Rybelsus (Drug) $103.66
- Viekira (Drug) $100.00
- LEQVIO (Drug) $96.30
- CoreValve Evolut (Device) $86.83
- Corlanor (Drug) $81.77
- Kerendia (Drug) $80.71
- ENTRESTO (Drug) $69.02
- Victoza (Drug) $65.56
- JARDIANCE (Drug) $59.44
- SPRAVATO (Drug) $56.77
- Otezla (Drug) $55.99
- CVI CONSUMABLES (Device) $55.97
- Ozempic (Drug) $53.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Trinity
David Wenk, M.d, M.D
Internal Medicine — Payments: $62,240
Internal Medicine $62,240
Mr. Jeffrey Vasta, M.d, M.D
Internal Medicine — Payments: $26,395
Internal Medicine $26,395
Dr. Jordan Young, M.d, M.D
Internal Medicine — Payments: $8,435
Internal Medicine $8,435
Jigneshkumar Patel, M.d, M.D
Internal Medicine — Payments: $7,415
Internal Medicine $7,415
Ghiath Kashlan, Md, MD
Internal Medicine — Payments: $4,332
Internal Medicine $4,332
Jose Roca, Md, MD
Internal Medicine — Payments: $3,153
Internal Medicine $3,153